Eprobemide

This classification denotes an antidepressant agent and antiarrhythmic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier URX5F7RDER. European Medicines Agency schedules Eprobemide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06585MIG. Eprobemide generally arises in the molecular formula C14H19CLN2O2. The term EPROBEMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, no. 3 1991, list 31.) EPROBEMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eprobemide under HS 29349990 and SITC 51579. As of Q4 2014, EPROBEMIDE remains the US FDA Preferred Term for this commodity. Eprobemide bears US NLM identifiers UMLS ID C1880541 and NCI Concept Code C65519. SMILES: Clc1ccc(C(=O)NCCCN2CCOCC2)cc1.